北京同仁堂股份有限公司2026年第一季度财报详解

一、报告亮点与关键数据

• 营业收入：2026年第一季度公司实现营业收入人民币46.64亿元，同比下降11.59%。
• 净利润：归属于上市公司股东的净利润为4.71亿元，同比下降19.07%。
• 扣除非经常性损益后的净利润：4.70亿元，同比下降19.15%。
• 基本每股收益：0.344元，同比下降19.06%。
• 加权平均净资产收益率：3.40%，同比减少0.92个百分点。
• 经营活动现金流量净额：9.42亿元，同比增长13.2%。
• 总资产：310.08亿元，较上年末增长1.26%。
• 归属于上市公司股东的所有者权益：140.85亿元，较上年末增长3.14%。

二、重要事项及可能影响股价的信息

• 业绩下滑：
  同仁堂今年一季度营业收入与净利润均出现两位数下滑，显示公司主营业务面临较大压力。营业收入同比减少11.59%，净利润更是同比下滑19.07%，扣非净利润降幅也达19.15%。业绩大幅下滑可能对股价产生负面影响。
• 现金流改善：
  尽管业绩承压，但经营活动现金流量净额同比增长13.2%，显示公司在回款或费用支出方面有所优化。投资活动现金流大幅流出，主要原因是购买结构性存款，筹资活动现金流也转为净流出，显示公司在资本运作上趋于谨慎。
• 费用变动及非经常性项目：
  研发费用同比大增41.61%，显示公司加大研发投入，或为未来新产品开发做准备。投资收益同比暴增24倍，主要来自结构性存款收益增加。信用减值损失扩大，提示应收账款风险需关注。
• 应收账款规模扩大：
  应收账款较年初大幅增加88.78%，公司解释为授予客户的信用额度滚动使用。虽称风险可控，但应收账款持续增长需警惕潜在回款问题。
• 存货减少：
  期末存货96.22亿元，较年初减少近10亿元，显示公司可能在去库存或销售压力下减少采购。
• 外币报表折算损失扩大：
  其他综合收益大幅减少42.62%，主要因外币财务报表折算差额变动，反映公司外币资产或业务受汇率波动影响。

三、股东结构与变动

• 控股股东为中国北京同仁堂（集团）有限责任公司，持股52.45%。
• 前十大股东结构稳定，无明显异常变动。
• 公司无优先股，无表决权恢复的优先股，无重大转融通出借股份情况。

四、财务报表及主要财务指标变化分析

• 交易性金融资产：期末余额8.60亿元，较年初大幅增加614.73%，主因购买结构性存款。
• 应交税费：期末余额2.91亿元，较年初增长62.29%，主要因增值税及所得税增加。
• 营业成本、费用：营业成本27.21亿元，同比减少。销售费用、管理费用及财务费用均有不同程度下降。研发费用显著上升。
• 净资产及分红：未分配利润增加至92.48亿元。期内无分红或利润分配计划披露。

五、现金流量及流动性状况

• 投资活动现金流量净额：净流出7.78亿元，主因结构性存款投资大幅增加。
• 筹资活动现金流量净额：净流出3.22亿元，主要因偿还借款及分配股利、支付利息等。
• 汇率变动影响：期末现金及现金等价物受到汇率影响减少4626万元。
• 期末现金及现金等价物余额：仍高达105.16亿元，流动性充裕。

六、对未来的展望与投资者风险提示

• 公司营收与利润双降，需关注后续市场需求与公司销售、回款能力。
• 应收账款和信用减值损失扩大，建议投资者关注公司应收款项质量。
• 研发投入大幅增加，若能带来新产品或新业务增长，未来有望改善业绩。
• 外部环境如汇率波动、政策变化等或继续影响公司盈利能力。

结论

本期同仁堂业绩出现明显下滑，尤其是净利润与扣非净利润降幅均超19%，且应收账款和信用减值损失增加，显示公司经营面临一定压力。但公司现金流改善、流动性充裕，且加大研发投入，显示公司有积极自救与转型信号。投资者需高度关注公司业绩恢复能力及结构性风险，业绩下滑、应收账款扩大等负面因素或对短期股价构成压力。

免责声明

本文基于公司公开披露的财报数据整理，仅供投资者参考，不构成任何买卖股票的建议。投资有风险，决策需谨慎。

English Version

Beijing Tong Ren Tang Co., Ltd. Q1 2026 Financial Report Detailed Analysis

1. Key Highlights & Data

• Operating Revenue: RMB 4.664 billion for Q1 2026, down 11.59% year-on-year.
• Net Profit: Net profit attributable to shareholders was RMB 471 million, down 19.07% YoY.
• Net Profit Excluding Non-Recurring Items: RMB 470 million, down 19.15% YoY.
• Basic EPS: RMB 0.344, down 19.06% YoY.
• ROE (Weighted): 3.40%, down 0.92 percentage points YoY.
• Net Operating Cash Flow: RMB 942 million, up 13.2% YoY.
• Total Assets: RMB 31.01 billion, up 1.26% from end-2025.
• Shareholders’ Equity: RMB 14.09 billion, up 3.14% from end-2025.

2. Important/Price Sensitive Information

• Performance Decline:
  Both revenue and net profit saw double-digit declines in Q1 2026, indicating significant pressure on the company’s core business. This downturn may negatively impact share price in the short term.
• Improved Cash Flow:
  Operating cash flow increased 13.2% YoY, reflecting improved cash collection or cost management. However, investment cash flow saw a large outflow due to increased purchase of structured deposits, and financing cash flow also turned negative, signaling more conservative capital operations.
• Expense/Non-Recurring Item Shifts:
  R&D expenses surged 41.61%, suggesting greater investment in innovation. Investment income soared due to higher returns from structured deposits. Credit impairment losses increased, signaling potential receivables risk.
• Receivables Expanded:
  Accounts receivable rose nearly 89%, attributed to rolling customer credit lines. Although the company claims risk is manageable, this increase warrants attention.
• Inventory Decreased:
  Ending inventory dropped by nearly RMB 1 billion, possibly reflecting destocking or sales pressure.
• Forex Translation Losses:
  Other comprehensive income dropped sharply due to forex translation differences, indicating the company is exposed to currency risk.

3. Shareholder Structure & Changes

• The controlling shareholder is China Beijing Tong Ren Tang Group with a 52.45% stake.
• The top ten shareholders are stable, with no significant changes.
• No preferred shares or material share lending via refinancing.

4. Financial Statement & Metric Changes

• Trading Financial Assets: Increased to RMB 860 million (+614.73%), mainly due to structured deposit purchases.
• Taxes Payable: Rose to RMB 291 million (+62.29%), reflecting higher VAT and income tax.
• Cost & Expenses: Operating cost decreased; selling, admin, and finance expenses all declined, while R&D shot up.
• Net Assets & Dividend: Retained earnings rose to RMB 9.25 billion. No dividend/distribution plan disclosed.

5. Cash Flow & Liquidity

• Net Investment Cash Outflow: Outflow of RMB 777 million, mainly due to structured deposit investments.
• Net Financing Cash Outflow: Outflow of RMB 322 million, mainly due to loan repayments and dividend/interest payments.
• Forex Impact: Cash and equivalents decreased by RMB 46.26 million due to exchange rates.
• Ending Cash Position: Still strong at RMB 10.52 billion.

6. Outlook & Risks

• Investors should closely watch if the company can stabilize and recover its core business performance in coming quarters.
• The sharp increase in accounts receivable and credit loss provisions signals potential risk in collections.
• Significant R&D spending could support future growth if new products materialize.
• External factors such as currency, regulation, and market demand may continue to affect profitability.

Conclusion

Beijing Tong Ren Tang’s Q1 2026 results show clear pressure on its core business, with notable declines in revenue and profit, and rising receivables/credit risks. However, improved cash flow and increased R&D investment provide a degree of resilience and potential for recovery. Investors should remain cautious regarding short-term risks and closely monitor the company’s turnaround efforts.

Disclaimer

This article is based on publicly disclosed financial data and is for informational purposes only. It does not constitute investment advice. Investing carries risk—please make decisions prudently.

View 同仁堂 Historical chart here